# Genomic Response Analysis of Heart Failure Therapy in African Americans

> **NCT02305095** · — · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 225 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** FDC I/H

## Key facts

- **NCT ID:** NCT02305095
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2022-09-30
- **Target enrollment:** 225 (ACTUAL)
- **Last updated:** 2023-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02305095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02305095, "Genomic Response Analysis of Heart Failure Therapy in African Americans". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02305095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
